These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 510999)

  • 1. Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus.
    Muechler EK; Kohler D
    Gynecol Oncol; 1979 Dec; 8(3):330-8. PubMed ID: 510999
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of action of estramustine.
    Tew KD
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):21-6. PubMed ID: 6364362
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo interaction between steroidal alkylating agents and oestrogen receptors in rabbit uteri.
    Asai M; Takeuchi H; Okada H
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):173-80. PubMed ID: 579532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.
    Daehlin L; Södergård R; Damber JE
    Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestradiol mustard.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():217-21. PubMed ID: 791835
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular effects of estramustine (Estracyt/Emcyt).
    Tew KD; Stearns ME
    Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
    [No Abstract]   [Full Text] [Related]  

  • 11. A study on the effects of estradiol and estramustine on gastrointestinal cell lines.
    Harrison JD; Watson S; Ellis IO; Morris DL
    Eur J Surg Oncol; 1990 Apr; 16(2):116-20. PubMed ID: 2182340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor and binding site for estramustine in metastatic malignant melanoma.
    Fernö M; Borg A; Ingvar C; Jönsson PE
    Anticancer Res; 1987; 7(4B):741-3. PubMed ID: 3314674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
    Hoisaeter PA
    Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of site-directed chemotherapy due to E2 as a drug carrier to the human endometrial adenocarcinoma cells in vitro].
    Yoshizumi N
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):637-45. PubMed ID: 3989343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
    Hoisaeter PA; Bakke A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):27-33. PubMed ID: 6364363
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of estramustine phosphate on carcinoma cell proliferation depends on the estrogen receptor status in the cytosol].
    Zgradić I
    God Vojnomed Akad; 1987; 29():77-81. PubMed ID: 3505486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.